BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210615T160000
DTEND;TZID=America/Toronto:20210615T170000
DTSTAMP:20210520T170816Z
CREATED:20210520T170816Z
LAST-MODIFIED:20210520T170816Z
UID:14565-1623772800-1623776400@scienceinboston.com
SUMMARY:Unleashing the Antitumor Immune Response
DESCRIPTION:One of the most powerful tools we have to fight cancer is the immune system. Indeed\, the breakthrough cancer therapies of the decade are based on activating the immune system to eliminate cancer cells. Although these immunotherapies have shown dramatic and durable responses in some cancers\, such as melanoma\, they have not been effective in highly aggressive malignancies such as pancreatic cancer. \nWhitehead Fellow Tobiloba Oni seeks to uncover the underlying reasons why pancreatic cancer is resistant to immunotherapies and develop new strategies to sensitize this aggressive malignancy to immune attack. Lessons learned from pancreatic cancer will be directly applicable to other aggressive malignancies. In this webinar\, Oni will outline the general principles of anti-tumor immune responses and discuss his lab’s strategies to unleash an immune attack against pancreatic cancer.
URL:https://scienceinboston.com/event/unleashing-the-antitumor-immune-response/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210615T160000
DTEND;TZID=America/Toronto:20210615T170000
DTSTAMP:20210520T170816Z
CREATED:20210520T170816Z
LAST-MODIFIED:20210520T170816Z
UID:27707-1623772800-1623776400@scienceinboston.com
SUMMARY:Unleashing the Antitumor Immune Response
DESCRIPTION:One of the most powerful tools we have to fight cancer is the immune system. Indeed\, the breakthrough cancer therapies of the decade are based on activating the immune system to eliminate cancer cells. Although these immunotherapies have shown dramatic and durable responses in some cancers\, such as melanoma\, they have not been effective in highly aggressive malignancies such as pancreatic cancer. \nWhitehead Fellow Tobiloba Oni seeks to uncover the underlying reasons why pancreatic cancer is resistant to immunotherapies and develop new strategies to sensitize this aggressive malignancy to immune attack. Lessons learned from pancreatic cancer will be directly applicable to other aggressive malignancies. In this webinar\, Oni will outline the general principles of anti-tumor immune responses and discuss his lab’s strategies to unleash an immune attack against pancreatic cancer.
URL:https://scienceinboston.com/event/unleashing-the-antitumor-immune-response-2/
LOCATION:Online
END:VEVENT
END:VCALENDAR